Edmondson RJ, O'Connell RL, Banerjee S, Mileshkin L, et al. Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903). Gynecol Oncol 2021 Oct 5. pii: S0090-8258(21)01379.
PMID: 34625284